SCHEMBL7656434

SCHEMBL7656434

COc1ccccc1C(=O)Nc1ccc2[nH]c3c(c2c1)CC(N(C)C)CC3

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.68
KCNK3 O14649 4/20 0.47
KCNK9 Q9NPC2 4/20 0.47
CASP3 P42574 2/20 0.46
KMT2A Q03164 5/20 0.45
MAPT P10636 4/20 0.45
MEN1 O00255 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TP53 P04637 3/20 0.45
NPC1 O15118 2/20 0.45
TSHR P16473 2/20 0.45
RAB9A P51151 2/20 0.45
POLB P06746 2/20 0.45
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
MAPK1 P28482 2/20 0.44
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656996 0.88 HTR1F (0.68) HTR1FKCNK3KCNK9KMT2AMAPT
SCHEMBL7662817 0.87 HTR1F (0.63) HTR1FKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL7663021 0.87 HTR1F (0.67) HTR1FCASP3KMT2AMAPTMEN1
SCHEMBL7658859 0.87 HTR1F (0.73) HTR1FKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL7654358 0.86 HTR1F (0.66) HTR1FKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL30909043 0.85 HTR1F (0.65) HTR1FKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL8116686 0.85 HTR1F (0.65) HTR1FKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL7656398 0.84 HTR1F (0.81) HTR1FKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL7666163 0.84 HTR1F (0.71) HTR1FKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL7656443 0.84 HTR1F (0.47) HTR1FKCNK3KCNK9CASP3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
WO-1998011895-A1 A METHOD FOR THE PREVENTION OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-03-26 WO disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1998006402-A1 TREATMENT OF THE COMMON COLD OR ALLERGIC RHINITIS ELI LILLY AND COMPANY (US) 1998-02-19 WO disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed